Mapping Regions Containing Binding Residues Within Functional Domains of Plasmodium Vivax and Plasmodium Knowlesi Erythrocyte-binding Proteins
Overview
Authors
Affiliations
Invasion of erythrocytes by malaria parasites is mediated by specific molecular interactions. Whereas Plasmodium vivax and Plasmodium knowlesi use the Duffy blood group antigen, Plasmodium falciparum uses sialic acid residues of glycophorin A as receptors to invade human erythrocytes. P. knowlesi uses the Duffy antigen as well as other receptors to invade rhesus erythrocytes by multiple pathways. Parasite ligands that bind these receptors belong to a family of erythrocyte-binding proteins (EBP). The EBP family includes the P. vivax and P. knowlesi Duffy-binding proteins, P. knowlesi beta and gamma proteins, which bind alternate receptors on rhesus erythrocytes, and P. falciparum erythrocyte-binding antigen (EBA-175), which binds sialic acid residues of human glycophorin A. Binding domains of each EBP lie in a conserved N-terminal cysteine-rich region, region II, which contains around 330 amino acids with 12 to 14 conserved cysteines. Regions containing binding residues have now been mapped within P. vivax and P. knowlesi beta region II. Chimeric domains containing P. vivax region II sequences fused to P. knowlesi beta region II sequences were expressed on the surface of COS cells and tested for binding to erythrocytes. Binding residues of P. vivax region II lie in a 170-aa stretch between cysteines 4 and 7, and binding residues of P. knowlesi beta region II lie in a 53-aa stretch between cysteines 4 and 5. Mapping regions responsible for receptor recognition is an important step toward understanding the structural basis for the interaction of these parasite ligands with host receptors.
Abebe A, Dieng C, Dugassa S, Abera D, Shenkutie T, Assefa A Malar J. 2024; 23(1):55.
PMID: 38395885 PMC: 10885561. DOI: 10.1186/s12936-024-04887-1.
Latif E, Noordin N, Shahari S, Amir A, Lau Y, Cheong F Parasitol Res. 2024; 123(1):105.
PMID: 38240877 DOI: 10.1007/s00436-024-08125-0.
Duffy antigen is expressed during erythropoiesis in Duffy-negative individuals.
Dechavanne C, Dechavanne S, Bosch J, Metral S, Redinger K, Watson Q Cell Host Microbe. 2023; 31(12):2093-2106.e7.
PMID: 38056457 PMC: 10843566. DOI: 10.1016/j.chom.2023.10.019.
Evolution of and resistance patterns for infection based on Duffy genotype and phenotype.
Picon-Jaimes Y, Lozada-Martinez I, Forero Buelvas M, Ardila Sarmiento A, Serrano Baez G, Nazareno Erazo D Infez Med. 2023; 31(3):350-358.
PMID: 37701383 PMC: 10495050. DOI: 10.53854/liim-3103-8.
Duffy Binding Protein-Based Vaccine: a Distant Dream.
Kar S, Sinha A Front Cell Infect Microbiol. 2022; 12:916702.
PMID: 35909975 PMC: 9325973. DOI: 10.3389/fcimb.2022.916702.